Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PROCEPT BioRobotics (PRCT) Raw Materials (2024 - 2026)

PROCEPT BioRobotics has reported Raw Materials over the past 3 years, most recently at $23.3 million for Q1 2026.

  • Quarterly Raw Materials rose 21.54% to $23.3 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $23.3 million through Mar 2026, up 21.54% year-over-year, with the annual reading at $18.6 million for FY2025, 2.35% up from the prior year.
  • Raw Materials was $23.3 million for Q1 2026 at PROCEPT BioRobotics, up from $18.6 million in the prior quarter.
  • Over five years, Raw Materials peaked at $23.3 million in Q1 2026 and troughed at $17.1 million in Q2 2025.
  • The 3-year median for Raw Materials is $18.5 million (2025), against an average of $19.1 million.
  • Year-over-year, Raw Materials increased 2.35% in 2025 and then increased 21.54% in 2026.
  • A 3-year view of Raw Materials shows it stood at $18.2 million in 2024, then grew by 2.35% to $18.6 million in 2025, then increased by 25.34% to $23.3 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Raw Materials are $23.3 million (Q1 2026), $18.6 million (Q4 2025), and $18.4 million (Q3 2025).